Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT00716300
Registration number
NCT00716300
Ethics application status
Date submitted
14/07/2008
Date registered
16/07/2008
Date last updated
18/02/2009
Titles & IDs
Public title
High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome
Query!
Scientific title
Functional Studies of High Density Lipoprotein in the Metabolic Syndrome
Query!
Secondary ID [1]
0
0
DC-HDL2008
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Metabolic Syndrome X
0
0
Query!
Condition category
Condition code
Metabolic and Endocrine
0
0
0
0
Query!
Metabolic disorders
Query!
Other
0
0
0
0
Query!
Research that is not of generic health relevance and not applicable to specific health categories listed above
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
1 - obese and insulin resistant subjects
2 - lean and normolipidaemic subjects
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Eligibility
Key inclusion criteria
MetS :the presence of at least three of the following:
* waist circumference > 102 cm, triglycerides > 1.7 mmol/L, HDL cholesterol < 1.05 mmol/L
* blood pressure = 130/ = 85 mmHg
* fasting glucose > 6.1 mmol/L
Lean control:
* BMI < 25 kg/m2
* waist circumference < 102 cm
* triglycerides < 1.0 mmol/L
* HDL-cholesterol > 1.3 mmol/L
Query!
Minimum age
20
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
* subjects with plasma LDL-cholesterol > 5 mmo/L
* diabetes mellitus (defined by oral glucose tolerance test)
* genetic hyperlipidaemia (e.g. FH)
* consumption of > 30 g alcohol/day
* apolipoprotein E2/E2 genotype
* macroproteinuria
* creatinaemia ( > 120 umol/L)
* hypothyroidism
* hepatic dysfunction (AST or ALT > 2x ULN)
* major systemic illness and use of steroids or other agents that may influence lipid metabolism
* cardiovascular event within the past 6 months
* subjects on hypocaloric diets
* anaemia; any significant illness that in the opinion of reviewing physician would bear on the study (e.g. heart murmur or psychiatric conditions)
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
UNKNOWN
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/07/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/12/2009
Query!
Actual
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
WA
Query!
Recruitment hospital [1]
0
0
University of Western Australia - Perth
Query!
Recruitment postcode(s) [1]
0
0
6000 - Perth
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
The University of Western Australia
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The aim of the study is to examine the kinetic, anti-oxidant, anti-inflammatory and cellular cholesterol efflux properties of high-density lipoprotein (HDL) in subjects with the metabolic syndrome (MetS) and lean individuals.
Query!
Trial website
https://clinicaltrials.gov/study/NCT00716300
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Gerald F Watts, MBBS
Query!
Address
0
0
The University of Western Australia
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Dick C Chan, PhD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
61-8-92240268
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT00716300
Download to PDF